Home > Newsletters > FDAnews Device Daily Bulletin > Singapore’s HSA Proposes Expedited Review Pathways for High-Risk Devices
FDAnews Device Daily Bulletin
Nov. 9, 2012 | Vol. 9 No. 221
Singapore’s HSA Proposes Expedited Review Pathways for High-Risk Devices
Medical device companies looking to introduce high-risk devices in Singapore will have the option of expedited registration evaluation routes, according to a draft guideline from the Health Sciences Authority (HSA). Excluded from the new approval pathway are hip, knee and shoulder joint replacement nonbioactive implants.
International Medical Device Regulatory Monitor
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.